Schedule 13G ownership disclosure
Terns Pharmaceuticals Inc
Security class unavailable · CUSIP: 880881107
Event date: 2022-08-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-22-001204
- Form type
- SC 13G
- Filer
- Flynn James E
- CIK
- CIK 1352546
- Filed
- Aug 16, 2022
- Reporting period
- Aug 16, 2022
- Description
- Schedule 13G beneficial ownership